Cure Sickle Cell

治疗镰刀细胞(CureSC)倡议是由国家心肺血液研究所(NIH/NHLBI)于2017年创建的，目的是： ·积极参与患者、家庭成员、护理人员和倡导者组成的镰状细胞病社区，共同努力走上治愈之路 ·利用出现的安全可靠的遗传疗法，扩大改善镰状细胞病患者生活的机会 ·利用政府机构、生物制药公司和研究人员之间的公私伙伴关系和合作，更快地推进新的创新疗法和技术

The Cure Sickle Cell (CureSC) Initiative was created in 2017 by the National Heart, Lung, and Blood Institute (NIH/NHLBI) to: • Actively engage the sickle cell disease community of patients, family members, caregivers and advocates to work together on a path to the cure • Utilize the emergence of safe reliable genetic therapies that broadens opportunities to improve the lives of individuals with sickle cell disease • Use public-private partnership and collaboration among government agencies, biopharmaceutical companies and researchers to result in more rapid advancement of new and innovative treatments and technologies